Validation of an ERAS Protocol in Gynecological Surgery (NCT03347409) | Clinical Trial Compass
CompletedNot Applicable
Validation of an ERAS Protocol in Gynecological Surgery
Italy166 participantsStarted 2017-06-14
Plain-language summary
Validation of ERAS interventional measures in elective gynecological surgery, for benign either malignant pathology.
Who can participate
Age range18 Years – 75 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age \>18 and \<75 years old
* Patients candidated for elective gynecological surgery for benign pathology
* Patients with diagnosis of gynecological neoplasm and candidated for elective gynecological surgery
* Signed consent form
* Karnofsky Performance Status \> 70
Exclusion Criteria:
* ASA score \> 3
* Contraindication to loco-regional anaesthesia
* Patients with ileus or subocclusive condition prior surgery
* Coagulation disorders
* Organ failure or severe disfunction (heart, renal, pulmonary, hepatic)
* Uncontrolled hypertension (\>180/95)
* Alcohol or drug abuser (current or previous)
* Unability to self-care (PFS \< 70)
* Comorbidity-Polypharmacy Score \> 22
* Psychiatric condition or language barriers
* Planned Intensive Care Recovery
What they're measuring
1
Shorter Length Of Hospitalization (LOH)
Timeframe: Up to 4 weeks after surgery
Trial details
NCT IDNCT03347409
SponsorAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia